Non-animal testing bill requires federal agencies to accept alternative in vitro methods.
This article was originally published in The Rose Sheet
Executive Summary
NON-ANIMAL TESTING BILL REQUIRES FEDERAL AGENCY ACCEPTANCE OF IN VITRO METHODS as alternatives to animal testing unless an agency meets certain criteria outlined in the legislation. The ICCVAM Authorization Act (HR 3946) would mandate that all federal bureaus, including FDA, the Environmental Protection Agency and the National Institutes of Health, review and adopt "any formal recommendations" on in vitro toxicological testing protocols proposed by the Inter-Agency Coordinating Committee for the Validation of Alternative Methods "to promulgate new regulations or draft new guidelines" regarding non-animal testing methods. Agencies would have 180 days to respond to ICCVAM once the committee made a final recommendation on an alternative method.